Literature DB >> 19292934

Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5).

Masaya Segawa1.   

Abstract

Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease) is an autosomal dominant dopa responsive dystonia caused by heterozygous mutation of the GCH 1 gene located on 14q22.1-q22.2. Although a number of mutations have been reported, the change remains highly stable within families, and causes a decrease in the tyrosine hydroxylase protein at the nigrostriatal (NS)-dopamine (DA) neuron terminal. In addition, decreased tetrahydrobiopterin levels early in the development affect DA receptors age-dependently, and produce a spectrum of specific symptoms attributed to neuronal changes traced to processes in the development of the NS-DA neuron, related striatal projection neurons, and the output projection of the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19292934

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  14 in total

1.  Occurrence of GCH1 gene mutations in a group of Indian dystonia patients.

Authors:  Tufan Naiya; Amar K Misra; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  J Neural Transm (Vienna)       Date:  2012-02-29       Impact factor: 3.575

2.  Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.

Authors:  Vincenzo Leuzzi; Claudia Carducci; Flavia Chiarotti; Daniela D'Agnano; Maria Teresa Giannini; Italo Antonozzi; Carla Carducci
Journal:  JIMD Rep       Date:  2012-04-18

3.  Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD).

Authors:  Anna De Rosa; Claudia Carducci; Carla Carducci; Silvio Peluso; Maria Lieto; Andrea Mazzella; Francesco Saccà; Vincenzo Brescia Morra; Sabina Pappatà; Vincenzo Leuzzi; Giuseppe De Michele
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

Review 4.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

5.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

6.  Dtorsin, the Drosophila ortholog of the early-onset dystonia TOR1A (DYT1), plays a novel role in dopamine metabolism.

Authors:  Noriko Wakabayashi-Ito; Olugbenga M Doherty; Hideaki Moriyama; Xandra O Breakefield; James F Gusella; Janis M O'Donnell; Naoto Ito
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

7.  Mutant human torsinA, responsible for early-onset dystonia, dominantly suppresses GTPCH expression, dopamine levels and locomotion in Drosophila melanogaster.

Authors:  Noriko Wakabayashi-Ito; Rami R Ajjuri; Benjamin W Henderson; Olugbenga M Doherty; Xandra O Breakefield; Janis M O'Donnell; Naoto Ito
Journal:  Biol Open       Date:  2015-04-17       Impact factor: 2.422

8.  A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.

Authors:  Oscar Bernal-Pacheco; Genko Oyama; Angela Briton; Andrew B Singleton; Hubert H Fernandez; Ramon L Rodriguez; Irene A Malaty; Michael S Okun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-10-10

9.  Dopa-responsive dystonia in a ten-year-old girl.

Authors:  Venkatesh Soma; Hussain Sadiq Mohammed; Ebrahim Riyas; Karuppasamy Murugesan
Journal:  J Family Med Prim Care       Date:  2012-07

10.  The analysis of genetic aberrations in children with inherited neurometabolic and neurodevelopmental disorders.

Authors:  Krystyna Szymańska; Krzysztof Szczałuba; Agnieszka Lugowska; Ewa Obersztyn; Marek Radkowski; Beata A Nowakowska; Katarzyna Kuśmierska; Jolanta Tryfon; Urszula Demkow
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.